Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 264 participants.

Also called NCT01349010

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 264 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01349010
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01349010. Randomized; quadruple masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2012-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia
Condition
Hyperlipidemia
Intervention (Drug)
Probucol
Intervention (Drug)
Placebo
Lead sponsor
Otsuka Beijing Research Institute (class: industry)

Record details

Record id
cardio:ct-nct01349010
Content hash
8198f1b9fdb3483801255f3f245cd601e2fbc647cc9f11307f030f1c7ed860ab